Compare OLP & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLP | QSI |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 165.3M |
| IPO Year | 1995 | N/A |
| Metric | OLP | QSI |
|---|---|---|
| Price | $21.50 | $0.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $27.50 | $1.00 |
| AVG Volume (30 Days) | 68.3K | ★ 2.9M |
| Earning Date | 03-05-2026 | 03-03-2026 |
| Dividend Yield | ★ 8.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $82,740,000.00 | N/A |
| Revenue This Year | $7.87 | N/A |
| Revenue Next Year | $4.40 | $618.07 |
| P/E Ratio | $19.27 | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $19.62 | $0.79 |
| 52 Week High | $26.63 | $3.10 |
| Indicator | OLP | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 31.07 | 33.04 |
| Support Level | $20.09 | N/A |
| Resistance Level | $21.64 | $1.11 |
| Average True Range (ATR) | 0.56 | 0.06 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 2.18 | 0.88 |
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.